Amesite Inc. Reports 2.4x Increase in Quarterly Revenue with Significant User Growth and Strong Customer Reviews

Reuters
17 May
Amesite Inc. Reports 2.4x Increase in Quarterly Revenue with Significant User Growth and Strong Customer Reviews

Amesite Inc. $(AMST)$, a developer of AI-powered enterprise solutions, reported a substantial increase in quarterly revenue, achieving a 2.4x growth from Q2 to Q3 2025. This growth was driven by their flagship app, NurseMagicTM, following targeted sales efforts and product enhancements. The company successfully reduced operating expenses while scaling sales. Revenue was evenly split between B2B and B2C sales. Amesite is expanding its market presence in the U.S., targeting large segments such as Skilled Nursing and Home Health Care Facilities. The company has also introduced a new, higher-priced tier for B2B users, responding to market demand for more intensive usage options. The company experienced a user growth of 1340% in Q3, attributed to the launch of paid subscriptions in Q2 and enhanced mobile marketing strategies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amesite Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-044897), on May 16, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10